- Home
- LYRA vs POLA Comparison
LYRA vs POLA Comparison
Compare LYRA & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- POLA
- Stock Information
- Founded
- LYRA 2005
- POLA 1979
- Country
- LYRA United States
- POLA United States
- Employees
- LYRA N/A
- POLA N/A
- Industry
- LYRA Medical/Dental Instruments
- POLA Industrial Machinery/Components
- Sector
- LYRA Health Care
- POLA Miscellaneous
- Exchange
- LYRA Nasdaq
- POLA Nasdaq
- Market Cap
- LYRA 11.3M
- POLA 11.5M
- IPO Year
- LYRA 2020
- POLA 2016
- Fundamental
- Price
- LYRA $6.37
- POLA $3.87
- Analyst Decision
- LYRA Hold
- POLA
- Analyst Count
- LYRA 1
- POLA 0
- Target Price
- LYRA $16.00
- POLA N/A
- AVG Volume (30 Days)
- LYRA 49.1K
- POLA 43.7K
- Earning Date
- LYRA 11-11-2025
- POLA 11-13-2025
- Dividend Yield
- LYRA N/A
- POLA N/A
- EPS Growth
- LYRA N/A
- POLA N/A
- EPS
- LYRA N/A
- POLA N/A
- Revenue
- LYRA $770,000.00
- POLA $11,967,000.00
- Revenue This Year
- LYRA N/A
- POLA N/A
- Revenue Next Year
- LYRA $106.28
- POLA N/A
- P/E Ratio
- LYRA N/A
- POLA N/A
- Revenue Growth
- LYRA N/A
- POLA 0.14
- 52 Week Low
- LYRA $3.81
- POLA $1.53
- 52 Week High
- LYRA $37.50
- POLA $5.75
- Technical
- Relative Strength Index (RSI)
- LYRA 39.68
- POLA 50.81
- Support Level
- LYRA $6.25
- POLA $3.38
- Resistance Level
- LYRA $7.30
- POLA $5.70
- Average True Range (ATR)
- LYRA 0.60
- POLA 0.58
- MACD
- LYRA -0.13
- POLA -0.19
- Stochastic Oscillator
- LYRA 8.98
- POLA 20.85
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.